University of Adelaide
The current economic model (where sales volumes and price determine the return on investment for a drug) does not foster appropriate antimicrobial use. Financial risks associated with antimicrobial resistance has resulted in a decline in the marketing of new drugs & insecurity of supply of current antimicrobials. This project is focused on the Australian market within a global context.
PhD candidature began Feb 2017 and is due for completion Feb 2020
Edits to this activity are currently being reviewed. If you want to update or request removal please email email@example.com.